Literature DB >> 29348675

STAC2 negatively regulates osteoclast formation by targeting the RANK signaling complex.

Eutteum Jeong1,2, Han Kyoung Choi1,2, Jin Hee Park1,2, Soo Young Lee3,4.   

Abstract

The receptor activator of nuclear factor-κB (RANK) protein activates various protein kinase signaling cascades, including those involving NF-κB, mitogen-activated protein kinase (MAPK), and Bruton tyrosine kinase (Btk)/tyrosine-protein kinase Tec. However, the mechanism underlying the negative regulation of RANK by downstream signaling molecules remains unclear. Here, we report that Src homology 3 domain and cysteine-rich domain-containing protein 2 (STAC2) is a novel RANK ligand-inducible protein that negatively regulates RANK-mediated osteoclast formation. STAC2 physically interacts with RANK and inhibits the formation of the RANK signaling complex, which contains Grb-2-associated binder 2 (Gab2) and phospholipase Cγ2 (PLCγ2), thus leading to the suppression of RANK-mediated NF-κB and MAPK activation. Furthermore, STAC2 overexpression limits Btk/Tec-mediated PLCγ2 phosphorylation via the interaction between STAC2 and Btk/Tec. Taken together, our results reveal a novel mechanism whereby RANK signaling is restricted by its physical interaction with STAC2.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29348675      PMCID: PMC6113229          DOI: 10.1038/s41418-017-0048-5

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  45 in total

Review 1.  Osteoclast differentiation and activation.

Authors:  William J Boyle; W Scott Simonet; David L Lacey
Journal:  Nature       Date:  2003-05-15       Impact factor: 49.962

2.  IRAK-M is a negative regulator of Toll-like receptor signaling.

Authors:  Koichi Kobayashi; Lorraine D Hernandez; Jorge E Galán; Charles A Janeway; Ruslan Medzhitov; Richard A Flavell
Journal:  Cell       Date:  2002-07-26       Impact factor: 41.582

3.  LPS-induced upregulation of SHIP is essential for endotoxin tolerance.

Authors:  Laura M Sly; Michael J Rauh; Janet Kalesnikoff; Christine H Song; Gerald Krystal
Journal:  Immunity       Date:  2004-08       Impact factor: 31.745

4.  Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts.

Authors:  Hiroshi Takayanagi; Sunhwa Kim; Takako Koga; Hiroshi Nishina; Masashi Isshiki; Hiroki Yoshida; Akio Saiura; Miho Isobe; Taeko Yokochi; Jun-ichiro Inoue; Erwin F Wagner; Tak W Mak; Tatsuhiko Kodama; Tadatsugu Taniguchi
Journal:  Dev Cell       Date:  2002-12       Impact factor: 12.270

5.  Stac3 has a direct role in skeletal muscle-type excitation-contraction coupling that is disrupted by a myopathy-causing mutation.

Authors:  Alexander Polster; Benjamin R Nelson; Eric N Olson; Kurt G Beam
Journal:  Proc Natl Acad Sci U S A       Date:  2016-09-12       Impact factor: 11.205

Review 6.  Bone resorption by osteoclasts.

Authors:  S L Teitelbaum
Journal:  Science       Date:  2000-09-01       Impact factor: 47.728

7.  Interferon regulatory factor-8 regulates bone metabolism by suppressing osteoclastogenesis.

Authors:  Baohong Zhao; Masamichi Takami; Atsushi Yamada; Xiaogu Wang; Takako Koga; Xiaoyu Hu; Tomohiko Tamura; Keiko Ozato; Yongwon Choi; Lionel B Ivashkiv; Hiroshi Takayanagi; Ryutaro Kamijo
Journal:  Nat Med       Date:  2009-08-30       Impact factor: 53.440

8.  The TRAF family of signal transducers mediates NF-kappaB activation by the TRANCE receptor.

Authors:  B R Wong; R Josien; S Y Lee; M Vologodskaia; R M Steinman; Y Choi
Journal:  J Biol Chem       Date:  1998-10-23       Impact factor: 5.157

9.  IL-1 receptor-associated kinase M is a central regulator of osteoclast differentiation and activation.

Authors:  Hongmei Li; Esteban Cuartas; Weiguo Cui; Yongwon Choi; Todd D Crawford; Hua Zhu Ke; Koichi S Kobayashi; Richard A Flavell; Agnès Vignery
Journal:  J Exp Med       Date:  2005-04-04       Impact factor: 14.307

10.  Impaired differentiation of osteoclasts in TREM-2-deficient individuals.

Authors:  Marina Cella; Cecilia Buonsanti; Carey Strader; Takayuki Kondo; Andrea Salmaggi; Marco Colonna
Journal:  J Exp Med       Date:  2003-08-11       Impact factor: 14.307

View more
  8 in total

1.  Allosteric regulators selectively prevent Ca2+-feedback of CaV and NaV channels.

Authors:  Jacqueline Niu; Ivy E Dick; Wanjun Yang; Moradeke A Bamgboye; David T Yue; Gordon Tomaselli; Takanari Inoue; Manu Ben-Johny
Journal:  Elife       Date:  2018-09-10       Impact factor: 8.140

2.  Stac Proteins Suppress Ca2+-Dependent Inactivation of Neuronal l-type Ca2+ Channels.

Authors:  Alexander Polster; Philip J Dittmer; Stefano Perni; Hicham Bichraoui; William A Sather; Kurt G Beam
Journal:  J Neurosci       Date:  2018-09-10       Impact factor: 6.167

3.  Molecular interactions of STAC proteins with skeletal muscle dihydropyridine receptor and excitation-contraction coupling.

Authors:  Dmitry Shishmarev; Emily Rowland; Shouvik Aditya; Srinivasan Sundararaj; Aaron J Oakley; Angela F Dulhunty; Marco G Casarotto
Journal:  Protein Sci       Date:  2022-05       Impact factor: 6.993

4.  Effects of Artemisia annua L. Essential Oil on Osteoclast Differentiation and Function Induced by RANKL.

Authors:  Wen Sun; Guangyue Yang; Fang Zhang; Chenguo Feng; Mingjie Liang; Pengfei Jia; Zhongliang Zhao; Hailing Guo; Yongfang Zhao
Journal:  Evid Based Complement Alternat Med       Date:  2022-04-07       Impact factor: 2.650

5.  RANKL signaling in bone marrow mesenchymal stem cells negatively regulates osteoblastic bone formation.

Authors:  Xiao Chen; Xin Zhi; Jun Wang; Jiacan Su
Journal:  Bone Res       Date:  2018-11-27       Impact factor: 13.362

6.  Oroxin B Attenuates Ovariectomy-Induced Bone Loss by Suppressing Osteoclast Formation and Activity.

Authors:  Jun-Ming Huang; Chen-Zhong Wang; Shun-Yi Lu; Zhe Wang; Zuo-Qin Yan
Journal:  Drug Des Devel Ther       Date:  2021-11-30       Impact factor: 4.162

7.  CYT387, a JAK-Specific Inhibitor Impedes Osteoclast Activity and Oophorectomy-Induced Osteoporosis via Modulating RANKL and ROS Signaling Pathways.

Authors:  Jing Li; Jiamin Liang; Liwei Wu; Yang Xu; Chengxiang Xiao; Xue Yang; Ran Sun; Jinmin Zhao; Jiake Xu; Qian Liu; Bo Zhou
Journal:  Front Pharmacol       Date:  2022-03-08       Impact factor: 5.810

8.  Plasma proteomic profiling of young and old mice reveals cadherin-13 prevents age-related bone loss.

Authors:  Yong Ryoul Yang; Mohammad Humayun Kabir; Jin Hee Park; Jae-Il Park; Jae Sook Kang; Shinyeong Ju; Yeo Jin Shin; Seung Min Lee; Jaemin Lee; Seokho Kim; Kwang-Pyo Lee; Soo Young Lee; Cheolju Lee; Ki-Sun Kwon
Journal:  Aging (Albany NY)       Date:  2020-05-12       Impact factor: 5.682

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.